Featured News

A new report released by an international group of researchers finds that pediatric celiac disease varies by region, and recommends a “low threshold for screening and further research on region-specific celiac disease triggers.”

The Celiac Disease Foundation is pleased to announce it will provide patient recruitment and eligibility screening for Anokion’s phase 1b/2 clinical trial for KAN-101.

Calling all Registered Dietitians! Earn a Certificate of Training in Treating Gluten-Related Disorders from the Academy of Nutrition and Dietetics and receive grant reimbursement from Proud Sponsor @Schar. Learn more and get free product from Schär with your reimbursement.

There is overwhelming scientific evidence that poor nutrition contributes to dozens of diseases, including many cancers, diabetes, heart disease, and obesity. Everyone, including government and the food industry, has a role to play in changing this fact.

On October 13, 2022 the Celiac Disease Foundation hosted the Ask-the-FDA Educational Webinar with representatives from the U.S. Food and Drug Administration and Coeliac UK.

The Celiac Disease Foundation announces its newest appointee, William Thurston, to its Board of Directors.

Please join the Celiac Disease Foundation for the upcoming Ask-the-FDA Educational Webinar.

Meet Celiac Disease Foundation Proud Sponsor empowerDX – an online shop for FDA-approved health testing that offers the at-home Celiac Disease Risk Gene Test.

Most of us have experienced the challenge of finding a public restroom, but for many, restroom access isn’t just a matter of convenience — it’s a serious medical issue.

The PROACTIVE Celiac Study is a phase 2 clinical trial testing the safety and effects of the investigational medication PRV-015.